Form D · Pharmaceuticals
CATACORE CORP
West Richland, WA · CIK 0001677388
Offering snapshot reported Feb 13, 2018 · SEC filing
- Reported sold
- $25K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 9, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 13, 2018 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Jun 24, 2016 | Initial | $30,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-305524
Series B Convertible Preferred Stock and Common Stock issuable upon conversion thereof.
Series B Convertible Preferred Stock & common stock issuable upon conversion thereof.
Source: Form D, filed Feb 13, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chuong Duong | Executive |
| Clark Moore | Director, Executive |
| Sam Nguyen | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2201 Diamond Head Way
West Richland, WA, 99353
West Richland, WA, 99353